
GC Biopharma Files IND for BARYCELA Phase 3 in Thailand
GC Biopharma, a South Korean pharmaceutical company, has sent an Investigational New Drug application to the Thailand Food and Drug Administration to start a Phase
GC Biopharma, a South Korean pharmaceutical company, has sent an Investigational New Drug application to the Thailand Food and Drug Administration to start a Phase
GC Biopharma, a top South Korean biopharmaceutical company, has entered into a Memorandum of Understanding (MOU) with the Thai Red Cross Society to strengthen their
GC Biopharma, a South Korean pharmaceutical company, announced that its varicella vaccine BARYCELA has received marketing authorization from the Drug Administration of Vietnam. Health Technology Insights: Zentiva